Literature DB >> 30184438

Interaction of Insulin-Like Growth Factor-Binding Protein 3 With Hyaluronan and Its Regulation by Humanin and CD44.

Robert Muterspaugh1, Deanna Price1, Daniel Esckilsen1, Sydney McEachern1, Jeffrey Guthrie1, Deborah Heyl1, Hedeel Guy Evans1.   

Abstract

Insulin-like growth factor-binding protein-3 (IGFBP-3) belongs to a family of IGF-binding proteins. Humanin is a peptide known to bind residues 215-232 of mature IGFBP-3 in the C-terminal region of the protein. This region of IGFBP-3 was shown earlier to bind certain glycosaminoglycans including hyaluronan (HA). Here, we characterized the binding affinities of the IGFBP-3 protein and peptide (215-KKGFYKKKQCRPSKGRKR-232) to HA and to humanin and found that HA binds with a weaker affinity to this region than does humanin. Either HA or humanin could bind to this IGFBP-3 segment, but not simultaneously. The HA receptor, CD44, blocked HA binding to IGFBP-3 but had no effect on binding of humanin to either IGFBP-3 or its peptide. Upon incubation of HA with CD44 and either IGFBP-3 protein or peptide, humanin was effective at binding and sequestering IGFBP-3 or peptide, thereby enabling access of CD44 to HA. We show that IGFBP-3 and humanin in the medium of A549 lung cancer cells can immunoprecipitate in a complex. However, the fraction of IGFBP-3 in the medium that is able to bind HA was not complexed with humanin suggesting that HA binding to the 215-232 segment renders it inaccessible for binding to humanin. Moreover, while the cytotoxic effects of IGFBP-3 on cell viability were reversed by humanin, blocking HA-CD44 interaction with an anti-CD44 antibody in combination with IGFBP-3 did not have an additive negative effect on cell viability suggesting that IGFBP-3 exerts its cytotoxic effects on cell survival through a mechanism that depends on HA-CD44 interactions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30184438     DOI: 10.1021/acs.biochem.8b00635

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Humanin Blocks the Aggregation of Amyloid-β Induced by Acetylcholinesterase, an Effect Abolished in the Presence of IGFBP-3.

Authors:  Deanna Price; Sadaf Dorandish; Asana Williams; Brandon Iwaniec; Alexis Stephens; Keyan Marshall; Jeffrey Guthrie; Deborah Heyl; Hedeel Guy Evans
Journal:  Biochemistry       Date:  2020-05-20       Impact factor: 3.162

2.  Biochemical determinants of the IGFBP-3-hyaluronan interaction.

Authors:  Sadaf Dorandish; Jonathan Devos; Bradley Clegg; Deanna Price; Robert Muterspaugh; Jeffrey Guthrie; Deborah L Heyl; Hedeel Guy Evans
Journal:  FEBS Open Bio       Date:  2020-07-22       Impact factor: 2.693

3.  Regulation of amyloid-β levels by matrix metalloproteinase-2/9 (MMP2/9) in the media of lung cancer cells.

Authors:  Sadaf Dorandish; Asana Williams; Sarah Atali; Sophia Sendo; Deanna Price; Colton Thompson; Jeffrey Guthrie; Deborah Heyl; Hedeel Guy Evans
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

Review 4.  The Molecular Structure and Role of Humanin in Neural and Skeletal Diseases, and in Tissue Regeneration.

Authors:  Sipin Zhu; Xiaoyong Hu; Samuel Bennett; Jiake Xu; Yuliang Mai
Journal:  Front Cell Dev Biol       Date:  2022-03-16

5.  IGFBP-3 Blocks Hyaluronan-CD44 Signaling, Leading to Increased Acetylcholinesterase Levels in A549 Cell Media and Apoptosis in a p53-Dependent Manner.

Authors:  Deanna Price; Robert Muterspaugh; Bradley Clegg; Asana Williams; Alexis Stephens; Jeffrey Guthrie; Deborah Heyl; Hedeel Guy Evans
Journal:  Sci Rep       Date:  2020-03-19       Impact factor: 4.379

6.  Interaction of amyloid beta with humanin and acetylcholinesterase is modulated by ATP.

Authors:  Sarah Atali; Sadaf Dorandish; Jonathan Devos; Asana Williams; Deanna Price; Jaylen Taylor; Jeffrey Guthrie; Deborah Heyl; Hedeel Guy Evans
Journal:  FEBS Open Bio       Date:  2020-11-18       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.